Why the study?
The study was conducted to analyze the effect of hydroxychloroquine or chloroquine associated with azithromycin on the QTc interval in Gabonese patients treated for COVID-19.
Does hydroxychloroquine or chloroquine combined with azithromycin cause QTc prolongation in patients with COVID-19?
Does hydroxychloroquine or chloroquine combined with azithromycin cause QTc prolongation in patients with COVID-19?
Treatment with hydroxychloroquine or chloroquine plus azithromycin in COVID-19 patients is associated with a high rate of early QTc prolongation, highlighting the need for careful electrocardiographic monitoring.
Answers are grounded in this paper and cite their sources.
May warrant early ECG monitoring in COVID-19 patients on these regimens; leaves open comparative risks and need for randomized confirmation.
The objective of this study was to analyze the effect of hydroxychloroquine or chloroquine associated with azithromycin on the QTc interval in Gabonese patients treated for COVID-19. Methods: This was an observational study conducted from April to June 2020, at the Libreville University Hospital Center in Gabon. Patients admitted for COVID-19 and treated with hydroxychloroquine or chloroquine, each combined with azithromycin were included. The QTc interval was measured upon admission and 48 h after starting treatment. The primary endpoint was QTc prolongation exceeding 60 ms and/or a QTc value exceeding 500 ms at 48 h. Results: Data from 224 patients, 102 (45.5%) who received hydroxychloroquine and 122 treated with chloroquine, were analyzed. The median baseline QTc was 396 (369–419) ms. After 48 h of treatment, 50 (22.3%) patients had a significant prolongation of QTc. This tended to be more frequent in patients treated with chloroquine (n = 33; 27.0%) than in those treated with hydroxychloroquine (n = 17; 16.7%) (p = 0.06). QTc prolongation exceeding 60 ms was found in 48 (21.3%) patients, while 11 patients had a (4.9%) QTc exceeding 60 ms at admission and exceeding 500 ms after 48 h. Conclusion: Early QTc prolongation is frequent in COVID-19 patients treated with hydroxychloroquine or chloroquine in association with azithromycin.
No takes yet. Share an insight, caveat, or question.
Bivigou et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: